Gothenburg, Sweden, 24. 07. 2008.
Denator AB announced today that the company is establishing a commercial sales network in Europe and the US.
Katarina Alenäs joins Denator to become the European Sales Director. Over the past 10 years, Ms. Alenäs has held sales, marketing and product management roles in several life science and diagnostics companies including Agilent Technologies, Bayer Healthcare Diagnositics and Aventis. In the US, Denator will be represented by Mr. John Lindsay, SciPartners Inc., a sales professional with more than 25 years of proven success in the introduction of novel, leading-edge instrumentation into the Life Sciences market.
Olof Sköld, CEO at Denator, stated: “Building up a sales organization within US and Europe is our next important step in preparation for the successful commercialization of Denator’s technology platform. So far, we have had excellent feedback from ongoing research collaborations. This, together with the recent decision of Professor Deelder’s laboratory at the Center for Infectious Diseases, Leiden University Medical School, Belgium to invest in our technology platform, has convinced us that we are well on the way to offering a unique technology that will significantly change the approach to sample preparation, offering major benefits throughout downstream analysis.”
Denator’s first commercial system for instant tissue stabilization will be launched at the HUPO meeting in Amsterdam in August, 2008.
About Denator
Denator intends to become the leading supplier of products that stabilize biological tissues and fluids from the moment of sampling. Stabilization and standardization of sampling processes upstream significantly enhances the quality of data obtained from analytical techniques used downstream. In proteomic and peptidomic investigations, enhanced data quality increases the reliability of data interpretation and can reveal novel proteins and peptides that would be lost or undetectable when using conventional preparation techniques. Based upon the company’s proprietary heat-inactivation technology platform, Denator is developing solutions that enable scientists to stop sample degradation instantly and maintain the stability of sample components throughout the analytical workflow. Established in 2004, Denator is headquartered at the Biotech Center in Gothenburg, Sweden. For more information visit: www.denator.com or contact:
Charlotte Emlind
Business Development
Denator AB
E-mail: charlotte.emlind@denator.com
Tel.: +46 31 41 28 91
Fax.: +46 41 28 40
